Log in to the research portal to view current pricing, stock, and bundles and order.
Sexual Health & Tanning research peptides in this catalog
The Melanocortin Receptor Family and Why It Is Studied
The melanocortin system is a network of five G-protein-coupled receptors, designated MC1R through MC5R, that respond to peptides derived from the proopiomelanocortin (POMC) precursor. Cleavage of POMC yields the endogenous agonists alpha-melanocyte-stimulating hormone (alpha-MSH), beta-MSH, gamma-MSH, and adrenocorticotropic hormone (ACTH). Each receptor subtype couples primarily to the stimulatory G-protein Gs, activating adenylyl cyclase and raising intracellular cyclic AMP (cAMP). In the published literature this cAMP signal is the common second-messenger readout researchers use to compare agonist potency across subtypes.
The peptides in this category are studied because they are synthetic analogs of alpha-MSH that bind one or more melanocortin receptors, allowing investigators to interrogate receptor function with greater metabolic stability than the native ligand. The endogenous hormone alpha-MSH is rapidly degraded, which limits its usefulness as a research probe. Cyclic and modified analogs such as Melanotan II resist enzymatic breakdown, giving experimental models a longer-acting tool to map receptor distribution, downstream signaling, and subtype selectivity.
Because the five subtypes occupy distinct tissues, the melanocortin system is a frequent subject of receptor-pharmacology research: MC1R on melanocytes, MC2R on the adrenal cortex, MC3R and MC4R in the central nervous system, and MC5R in exocrine tissue. The compounds here are used in research contexts to distinguish the contributions of MC1R-driven pigment biology from MC4R-driven central signaling. All such work is conducted in vitro or in animal models for research purposes only.
MC1R and Melanogenesis: The Pigmentation Branch
MC1R is expressed on melanocytes, the pigment-producing cells of the skin and hair follicle. In the published animal and cell-culture literature, agonist binding at MC1R elevates cAMP, which activates protein kinase A and the transcription factor MITF (microphthalmia-associated transcription factor). MITF in turn upregulates tyrosinase and related enzymes that drive melanogenesis, the biosynthesis of melanin. A central finding in this research is the shift from red-yellow pheomelanin toward brown-black eumelanin when MC1R signaling is sustained.
Melanotan I (Afamelanotide) and Melanotan II are the analogs most studied in this pigmentation context. Melanotan I is a linear alpha-MSH analog investigated in research models for relatively selective melanocortin activity, while Melanotan II is a cyclic, more broadly potent analog that activates multiple subtypes. In cell-based assays these peptides have been used to quantify tyrosinase induction and eumelanin output, serving as reference agonists for studying the melanocortin-melanogenesis axis.
It is important to frame this strictly as receptor biology observed in research systems. The descriptions above concern melanocyte signaling cascades documented in vitro and in animal studies. Nothing here describes an outcome in a person, and these materials are not intended to produce pigmentation, tanning, or any effect in humans. They are research chemicals supplied for laboratory investigation only.
MC4R and Central Signaling: The Bremelanotide Branch
MC4R is densely expressed in the hypothalamus and other central-nervous-system regions, where the melanocortin literature links it to the regulation of energy balance and to neural circuits involved in sexual-function signaling in animal models. Unlike MC1R, MC4R sits within neuronal pathways rather than pigment cells, which is why agonists at this subtype are studied for entirely different research questions.
PT-141 (Bremelanotide) is a melanocortin agonist studied for its activity at central melanocortin receptors, with research interest in MC4R. It is a metabolite-derived analog structurally related to Melanotan II but investigated specifically for central rather than pigmentary signaling. In preclinical and animal-model research, MC4R agonism has been examined for its role in neural pathways, distinguishing it from the peripheral MC1R pigment branch.
The contrast between MC1R-directed and MC4R-directed analogs illustrates why subtype selectivity is a core theme in melanocortin research. A broadly active agonist engages both pigment and central receptors, whereas more selective tools allow investigators to isolate one branch. Researchers use radioligand binding and cAMP accumulation assays across cloned human receptor subtypes to quantify where each peptide sits on this selectivity spectrum. As with all items in this category, PT-141 is offered for in-vitro and animal research use only and is not an approved product for human use.
Kisspeptin and the Reproductive Axis: Upstream of GnRH
Kisspeptin sits in a different but biologically adjacent research domain: the hypothalamic-pituitary-gonadal (HPG) axis. Kisspeptin is the peptide product of the KISS1 gene and acts on the receptor KISS1R (also called GPR54). Unlike the melanocortin analogs, kisspeptin does not act on melanocortin receptors; it is included in this category because the published literature positions it as a master upstream regulator of the reproductive axis studied alongside sexual-function research.
In animal and in-vitro studies, kisspeptin signaling at KISS1R on gonadotropin-releasing hormone (GnRH) neurons is described as a primary driver of GnRH secretion. The so-called KNDy neurons of the arcuate nucleus, which co-express kisspeptin, neurokinin B, and dynorphin, are studied as a pulse-generating network that paces GnRH release. GnRH in turn governs pituitary output of luteinizing hormone and follicle-stimulating hormone. This places kisspeptin at the very top of the reproductive cascade in research models.
The research value of kisspeptin lies in this upstream position. Because it acts before GnRH, it is used as a probe to study the timing and amplitude of reproductive-axis signaling in preclinical systems. All such investigation is confined to laboratory and animal models. These descriptions are not claims about any effect in humans, and kisspeptin here is a research chemical not approved for human or animal consumption.
How Researchers Distinguish and Compare the Four Compounds
Because these peptides span two receptor systems, investigators compare them along a few defined axes. The first is receptor target: Melanotan I and Melanotan II engage melanocortin receptors with emphasis on MC1R pigment biology; PT-141 is studied at central melanocortin receptors with interest in MC4R; kisspeptin acts on KISS1R upstream of GnRH and is unrelated to the melanocortin family. Naming the receptor first prevents conflating distinct mechanisms.
The second axis is selectivity and structure. Melanotan I is a linear analog studied for more selective melanocortin activity, while Melanotan II is a cyclic analog with broader subtype potency and greater enzymatic stability. PT-141 is structurally related to the Melanotan II scaffold but investigated for central signaling. These structural distinctions are quantified in binding-affinity and cAMP-potency tables across cloned receptor subtypes, which is how the literature ranks the analogs.
The third axis is pathway position. The three melanocortin analogs act at cell-surface melanocortin receptors that signal through cAMP, whereas kisspeptin operates one level higher in the neuroendocrine hierarchy, modulating the neurons that release GnRH. Keeping these reference points straight lets researchers design clean experiments that attribute an observed signal to the correct receptor and pathway. Every comparison here is for research characterization only.
Reconstitution, Storage, and Purity Considerations
These peptides are typically supplied as lyophilized (freeze-dried) powder, the standard format for research peptides because the dry state maximizes stability during shipping and storage. In published laboratory practice, lyophilized melanocortin and kisspeptin analogs are stored desiccated and frozen, often at or below minus 20 degrees Celsius for longer-term holding, with protection from light and moisture to limit degradation of the peptide chain.
For in-vitro work, researchers reconstitute lyophilized material with a suitable solvent such as bacteriostatic or sterile water, swirled gently rather than shaken to avoid mechanical stress on the peptide. Reconstituted stock is generally kept refrigerated and used within a limited window, since peptides in solution degrade faster than the dry powder. Aliquoting before freezing is a common practice to avoid repeated freeze-thaw cycles, which are known in the literature to reduce peptide integrity.
Purity is a central quality parameter in this class. Analytical reports based on high-performance liquid chromatography (HPLC) and mass spectrometry are used to confirm identity and quantify purity, commonly at or above 98 percent for research-grade material. These handling and analytical notes describe standard laboratory procedure for research chemicals only. None of this constitutes guidance for human or animal use; all compounds in this category are for laboratory research use only, are not FDA approved, and are not for consumption.
Research application areas
Choosing a compound for your research
Identify the receptor system first: choose Melanotan I or Melanotan II for MC1R and melanogenesis research, PT-141 for central MC4R-focused melanocortin work, and Kisspeptin for KISS1R and reproductive-axis (GnRH) studies.
For pigment-pathway selectivity questions, contrast linear Melanotan I (studied for more selective melanocortin activity) against cyclic Melanotan II (broader subtype potency and greater enzymatic stability).
Select PT-141 (Bremelanotide) when the research question concerns central melanocortin signaling rather than peripheral pigment biology, noting its structural relationship to the Melanotan II scaffold.
Select Kisspeptin when the model targets the neuroendocrine level above the melanocortin receptors, since it acts on KISS1R and GnRH neurons rather than any melanocortin subtype.
Confirm HPLC and mass-spectrometry purity documentation (commonly 98 percent or higher) and lyophilized format before selecting any compound for assay-grade research.
Remember that every item is supplied for in-vitro and animal research use only, is not FDA approved, and is not for human or animal consumption.
Per-compound reference data: PT-141 reference · Melanotan II reference · Kisspeptin reference.
Frequently asked questions
What is the melanocortin pathway and which receptors do these peptides target?
The melanocortin pathway comprises five G-protein-coupled receptors, MC1R through MC5R, activated by alpha-MSH and related POMC-derived peptides that signal through cyclic AMP. In this category, Melanotan I and Melanotan II are studied at MC1R for pigment biology, and PT-141 is studied at central melanocortin receptors including MC4R. Kisspeptin is the exception: it targets KISS1R, not a melanocortin receptor. All are research chemicals for laboratory use only.
How does MC1R differ from MC4R in melanocortin research?
MC1R is expressed on melanocytes and, in research models, drives melanogenesis through the MITF-tyrosinase cascade, shifting pigment toward eumelanin. MC4R is expressed in the central nervous system and is studied in neuronal circuits related to energy balance and sexual-function signaling in animals. Melanotan analogs are common MC1R research tools, while PT-141 is studied for central MC4R activity. These are receptor-biology distinctions observed in vitro and in animal studies, not human outcomes.
Why is Kisspeptin grouped with melanocortin peptides if it acts on a different receptor?
Kisspeptin is grouped here because it is studied in the same reproductive and sexual-health research domain, even though it does not bind melanocortin receptors. It acts on KISS1R (GPR54) on GnRH neurons and functions upstream of the melanocortin-independent hypothalamic-pituitary-gonadal axis. The published literature treats it as a master regulator of GnRH release via the KNDy-neuron network, making it a complementary research probe in reproductive neuroendocrinology studies.
What distinguishes Melanotan I from Melanotan II in research use?
Melanotan I (Afamelanotide) is a linear alpha-MSH analog investigated for relatively selective melanocortin activity, whereas Melanotan II is a cyclic analog with broader subtype potency and greater resistance to enzymatic breakdown. In cell-based research the cyclic structure of Melanotan II gives it longer-acting agonist behavior across multiple receptor subtypes. Researchers select between them based on whether the study needs narrower MC1R focus or broader melanocortin engagement, characterized through binding and cAMP assays.
How are these research peptides typically stored and reconstituted?
They are supplied as lyophilized powder and, in standard laboratory practice, stored desiccated and frozen at or below minus 20 degrees Celsius, protected from light and moisture. For in-vitro work researchers reconstitute with sterile or bacteriostatic water, swirling gently, then refrigerate the stock and aliquot to avoid repeated freeze-thaw cycles that degrade peptide integrity. These notes describe research handling only and are not instructions for any human or animal use.
Are these compounds approved for human or animal use?
No. Every compound in this category, including PT-141, Melanotan I, Melanotan II, and Kisspeptin, is supplied strictly for in-vitro and laboratory research use only. They are not approved by the FDA for the uses discussed, are not therapeutics, and are not for human or animal consumption. All descriptions on this page concern receptor biology and signaling documented in preclinical, in-vitro, and animal research literature, not effects in people.
Create a free research account to view current pricing, real-time stock, and bundle options, then submit your order for approval.
Related: What are peptides? · Reference library · Cost & pricing · Price comparison · Research guides · Order portal